Spring sale — 20% off your first order with code SPRING20 at checkout

For in-vitro research only · Not for human use · 18+

Back to catalogue
Aussie Peptides CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) vial — lyophilised research peptide powder in a clear glass vial with the cream Aussie Peptides label, coral accent bar, circular Aussie Peptides logo and silver crimp cap. Performance research peptide Australia, ≥99% HPLC verified with batch CoA, dispatched Australia-wide, research use only.
Performance
Save $15.00

Aussie Peptides · AU

CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg)

$149.00

$164.00

1

Why Aussie Peptides

  • Lot-matched certificate

    Independently analysed before release; look the lot up on the verification page.

  • Strictly research use

    Not for human or veterinary consumption.

  • Express AU shipping

    Discreet, fully tracked, 1–3 business days.

Aussie Peptides brand mark

Aussie Peptides · specification

CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg)

Presentation
10mg sealed glass vial
SKU
CJC-1295-IPAMORELIN-BLEND-10MG
Format
Lyophilised powder
Purity
≥99% release specification by RP-HPLC — result recorded per lot
Documentation
Batch-specific Certificate of Analysis
Storage
2–8 °C, protect from light
Dispatch
Cold-chain, same-day, Australia-wide
Origin
Packed in Australia · Aussie Peptides
Category
Performance

Specifications are standardised across the Aussie Peptides range. Batch values — lot number, assay result and expiry — are printed on the vial and matched to the Certificate of Analysis supplied with your order.

The Aussie Peptides label

Aussie Peptides CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) vial — lyophilised research peptide powder in a clear glass vial with the cream Aussie Peptides label, coral accent bar, circular Aussie Peptides logo and silver crimp cap. Performance research peptide Australia, ≥99% HPLC verified with batch CoA, dispatched Australia-wide, research use only.
  • 1

    Coral spine + hexagon mark

    Every Aussie Peptides vial carries the same coral spine and molecular hexagon so a genuine vial is recognisable at a glance.

  • 2

    Compound, strength, fill volume

    Printed in a fixed position on the cream label — compound name, strength in milligrams, and vial volume.

  • 3

    LOT + EXP fields

    Hand-stamped per batch and matched to the Certificate of Analysis you can look up on our CoA page.

  • 4

    Lot-tested by RP-HPLC — research use only

    The compliance line appears on every label, on every SKU, without exception.

CJC-1295 & Ipamorelin — strengths and blends

Same batch-tested material, different presentations. Higher-strength vials lower the cost per milligram; blends arrive pre-combined in a single lyophilised cake so one reconstitution covers both compounds.

Laboratory handling · Research peptide

Usage & handling guide

A standard lyophilised research peptide. Reconstitute gently, aliquot for single use, and keep the stock cold and dark.

Reconstitution
2 mL bacteriostatic or sterile water for a standard bench stock
Stock concentration
≈ 5.0 mg/mL (10 mg ÷ 2 mL)
Storage once reconstituted
2–8 °C, upright, protected from light
Stability window
Use reconstituted stock within 14–21 days at 2–8 °C; freeze single-use aliquots at −20 °C for longer holds
  1. 1 · Equilibrate before opening

    Let the sealed vial reach room temperature before breaking the seal. Opening a cold vial draws in moisture, and lyophilised peptide is hygroscopic.

  2. 2 · Add diluent down the wall

    Direct the diluent slowly against the inside wall of the vial rather than onto the powder cake. A fast stream shears the peptide and lowers recovery.

  3. 3 · Dissolve, never shake

    Swirl or roll gently until the cake is fully dissolved. Vortexing or shaking foams the solution and denatures peptide at the air–liquid interface.

  4. 4 · Inspect the solution

    A correctly reconstituted stock is clear and free of visible particulate. Cloudiness, fibres, or a film indicates the stock should be discarded.

  5. 5 · Aliquot for single use

    Split the stock into single-use aliquots in low-bind tubes and label each with compound, concentration, LOT and date. Repeated freeze–thaw is the most common cause of lost potency.

  6. 6 · Record against the CoA

    Log the LOT number and the batch Certificate of Analysis reference alongside your results so every data point is traceable to a tested batch.

Figures above are worked examples for bench preparation only. Always calculate your own working concentrations from the strength printed on the vial, the exact diluent volume you added, and the batch assay result on the Certificate of Analysis.

Safety & handling cautions

  • One freeze–thaw per aliquot — repeated cycling is the most common cause of lost activity.
  • Always calculate working concentrations from the vial strength on the label and the exact diluent volume you added.
  • Wear appropriate PPE, work in a clean and controlled area, and dispose of vials, sharps and unused stock in line with your institution’s waste procedures.

Important — no dosage advice

This guide covers reconstitution, storage and laboratory handling only. Aussie Peptides does not publish, supply or advise on human or veterinary dosing, administration schedules, or therapeutic protocols for any product, and nothing here should be interpreted as such.

All products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not medicines, are not evaluated by the TGA, and are not for human or animal consumption. Nothing on this page is medical advice — speak to a qualified healthcare professional about any health matter.

In depth

CJC-1295 + Ipamorelin Blend ( / ) in Australia — research notes

The CJC-1295 + Ipamorelin blend combines 5mg of the no-DAC GHRH analogue with 5mg of the selective ghrelin-receptor agonist in one lyophilised vial — the single most-referenced pairing in growth-hormone secretagogue research.

  • 5mg CJC-1295 (no DAC) + 5mg Ipamorelin, 1:1
  • One reconstitution, one refrigerated stock
  • Both sequences confirmed on the blend certificate

Why these two are studied together

They act on separate receptor pathways: CJC-1295 (no DAC) as a GHRH analogue and Ipamorelin at the ghrelin receptor. The literature examines them jointly because the pathways are complementary rather than redundant, which is what makes a fixed-ratio blend a reasonable format for the combination rather than a marketing convenience.

Blend composition and dilution

10mg total at a 1:1 ratio. 5mL of bacteriostatic water yields 1mg/mL of each component; a 0.3mL draw therefore contains 300mcg of CJC-1295 and 300mcg of Ipamorelin. Both sequences are confirmed on the blend's own certificate by mass spectrometry.

When to buy singles instead

Choose separate vials whenever the protocol needs the two components varied independently, or when one is being titrated against a fixed amount of the other. The blend is for combination work at a fixed ratio. Every vial ships from our Australian storage and dispatch facility with a lot-matched certificate of analysis and cold-chain packaging.

About this compound

Research overview

A pre-blended research vial containing 5mg CJC-1295 (no DAC) and 5mg Ipamorelin in one lyophilised cake — the most commonly paired combination in growth-hormone secretagogue literature, supplied ready to reconstitute as a single stock. Each component is HPLC verified ≥99% pure before blending and the finished lot carries its own Certificate of Analysis. For research purposes only. Not for human consumption.

Compliance

For in‑vitro research only.

Products supplied for laboratory research. Not for human or veterinary consumption. Buyer assumes all responsibility.

Read compliance →

Questions

CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) — frequently asked

What is CJC-1295 + Ipamorelin Blend ( / )?+

A pre-blended research vial containing 5mg CJC-1295 (no DAC) and 5mg Ipamorelin in one lyophilised cake — the most commonly paired combination in growth-hormone secretagogue literature, supplied ready to reconstitute as a single stock. Each component is HPLC verified ≥99% pure before blending and the finished lot carries its own Certificate of Analysis. Aussie Peptides supplies CJC-1295 + Ipamorelin Blend ( / ) strictly as an in-vitro laboratory reference material — it is not a therapeutic good and is not for human or veterinary use.

How pure is Aussie Peptides CJC-1295 + Ipamorelin Blend ( / )?+

Each CJC-1295 + Ipamorelin Blend ( / ) lot is analysed by RP-HPLC for purity and by mass spectrometry for identity, and is released against a ≥99% purity specification. The result belongs to that lot: the number printed on your vial maps to its own Certificate of Analysis, so the figure can be recorded alongside your experimental data rather than assumed.

How is CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) reconstituted and stored in the lab?+

2 mL bacteriostatic or sterile water for a standard bench stock That gives a working stock of roughly ≈ 5.0 mg/mL (10 mg ÷ 2 mL). Reconstituted vials are held at 2–8 °c, upright, protected from light, and use reconstituted stock within 14–21 days at 2–8 °c; freeze single-use aliquots at −20 °c for longer holds Sealed lyophilised 10mg vials are stable long-term at -20°C.

Is it legal to buy CJC-1295 + Ipamorelin Blend ( / ) in Australia?+

CJC-1295 + Ipamorelin Blend ( / ) is supplied in Australia for in-vitro laboratory research only. It is not approved by the TGA as a therapeutic good and is not sold for human or veterinary consumption. Purchasers must be 18 or over and are responsible for handling, storage and disposal under their own institutional and legal requirements.

How much is CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) and how fast does it ship?+

CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg) is $149.00. It is in stock and dispatched same business day on orders placed before 12pm AEST. Shipping is A$12.95 express Australia-wide and free over A$199, sent discreetly packaged and fully tracked, typically 1–3 business days.

What does the research on CJC-1295 + Ipamorelin Blend ( / ) investigate?+

Published work on this class focuses on growth-hormone secretagogue pathways and receptor binding behaviour in laboratory models. Nothing on this page is a dosing protocol, medical advice, or a claim of therapeutic benefit — it summarises what the published literature examines.

Keep exploring

More from the Performance range